抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn)：

1. 磷酸化雷帕霉素靶蛋白復(fù)合體2抗體規(guī)格 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析；

2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個不同的分子比來篩選最適條件；

3.用NHSB量過量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活；

4.由于抗體的氨基不易接近可能造成生物素化不足,此時可加入去污劑如 Triton x-100, Tween20等；

5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時,或位于酶的催化位點(diǎn)時,生物素化會降低或損傷抗體蛋白的結(jié)合力或活性；

6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合；

7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會對生物素化抗體與親和素的結(jié)合產(chǎn)生競爭作用；

8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對某些細(xì)胞可導(dǎo)致高本底。

產(chǎn)品訂購信息：
英文名稱  Anti-Phospho-Rictor (Thr1135) 

中文名稱   磷酸化雷帕霉素靶蛋白復(fù)合體2抗體規(guī)格 

別    名  Rictor(Phospho-Thr1135); Rictor(Phospho-T1135); p-Rictor(Thr1135); p-Rictor(T1135); AVO3; AVO3 homolog; hAVO3; DKFZp686B11164; hAVO3; KIAA1999; Likely ortholog of mouse TORC2 specific protein AVO3 (S. cerevisiae); mAVO3; MGC39830; PIA; Pianissimo; Rapamycin insensitive companion of mTOR; Rapamycin-insensitive companion of mTOR; rictor; RICTR; RICTR_HUMAN; RPTOR independent companion of MTOR complex 2; TORC2 specific protein AVO3.

濃    度   1mg/1ml

規(guī) 格  0.1ml/100μg

抗體來源   Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Dog, Pig, Cow, Rabbit, Guinea Pig 

產(chǎn)品類型   一抗 磷酸化抗體  

研究領(lǐng)域     細(xì)胞生物 免疫學(xué) 信號轉(zhuǎn)導(dǎo) 轉(zhuǎn)錄調(diào)節(jié)因子

蛋白分子量  predicted molecular weight: 189kDa

性    狀   Lyophilized or Liquid

免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human Rictor around the phosphorylation site of Thr1135 

亞    型   IgG

純化方法   affinity purified by Protein A

儲 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化雷帕霉素靶蛋白復(fù)合體2抗體規(guī)格 產(chǎn)品應(yīng)用    WB=1:100-1000 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 RICTOR and MTOR (FRAP1; MIM 601231) are components of a protein complex that integrates nutrient- and growth factor-derived signals to regulate cell growth (Sarbassov et al., 2004 [PubMed 15268862]).[supplied by OMIM, Mar 2008].

Function : Subunit of mTORC2, which regulates cell growth and survival in response to hormonal signals. mTORC2 is activated by growth factors, but, in contrast to mTORC1, seems to be nutrient-insensitive. mTORC2 seems to function upstream of Rho GTPases to regulate the actin cytoskeleton, probably by activating one or more Rho-type guanine nucleotide exchange factors. mTORC2 promotes the serum-induced formation of stress-fibers or F-actin. mTORC2 plays a critical role in AKT1 'Ser-473' phosphorylation, which may facilitate the phosphorylation of the activation loop of AKT1 on 'Thr-308' by PDK1 which is a prerequisite for full activation. mTORC2 regulates the phosphorylation of SGK1 at 'Ser-422'. mTORC2 also modulates the phosphorylation of PRKCA on 'Ser-657'. Plays an essential role in embryonic growth and development.

Subunit : Part of the mammalian target of rapamycin complex 2 (mTORC2) which contains MTOR, MLST8, PRR5, RICTOR, MAPKAP1 and DEPTOR. Contrary to mTORC1, mTORC2 does not bind to and is not sensitive to FKBP12-rapamycin. Binds directly to MTOR and PRR5 within the TORC2 complex. May interact with PRR5L.

Post-translational modifications : Phosphorylated by MTOR; when part of mTORC2. Phosphorylated at Thr-1135 by RPS6KB1; phosphorylation of RICTOR inhibits mTORC2 and AKT1 signaling.

Similarity : Belongs to the pianissimo family.

Database links : NCBI Reference Sequence: NP_689969.2 UniProtKB/Swiss-Prot: Q6R327.1

抗體的鑒定：

1）磷酸化雷帕霉素靶蛋白復(fù)合體2抗體規(guī)格 抗體的效價(jià)鑒定：不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來鑒定。

2）抗體的特異性鑒定：抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識別能力?？贵w的特異性高,它的識別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來表示。交叉反應(yīng)率可用競爭抑制試驗(yàn)測定。以不同濃度抗原和近似抗原分別做競爭抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時的濃度,并按公式計(jì)算交叉反應(yīng)率。 

如果所用抗原濃度IC50濃度為pg/管,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時,表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。

3）抗體親和力：是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol?？贵w親和力的測定對抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。

DYKDDDDK Tag(CT)/Flag-Tag 標(biāo)簽DYKDDDDK Tag分支肽Multi-class antibodies規(guī)格： 0.5mg

Anti-5-HTR4 5-羥色胺受體4抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh Phospho-c-Kit(Ser721) 磷酸化原癌基因c-kit抗體 規(guī)格 0.1ml

羊抗人白蛋白 0.5ml 國產(chǎn)

XRCC4 英文名稱： X射線修復(fù)交叉互補(bǔ)蛋白4抗體 0.2ml

C21orf106 英文名稱： 21號染色體開放閱讀框106抗體 0.2ml

Anti-5-HTR4 5-羥色胺受體4抗體Multi-class antibodies規(guī)格： 0.2ml

Anti-TREM2/FITC 熒光素標(biāo)記兔抗人、大、小鼠髓系細(xì)胞觸發(fā)受體2抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Secretin 分泌素(抗原)Multi-class antibodies規(guī)格： 0.5mg

Trop-2抗體 Anti-Trop-2 0.1ml

SCN4B 英文名稱： 通道亞基β4抗體 0.2ml

Ephrin B3 英文名稱： 酪酸蛋白激酶B3抗體 0.2ml

Rhesus antibody Rh phospho-IRS1(Ser302) 磷酸化受體底物-1抗體 規(guī)格 0.1ml

Secretin 分泌素(抗原)Multi-class antibodies規(guī)格： 0.5mg

SAMD3 英文名稱： SAMD3蛋白抗體 0.2ml

ERGI3 英文名稱： 內(nèi)質(zhì)網(wǎng)定位蛋白ERGI3抗體 0.2ml

細(xì)胞分裂周期蛋白6抗體 Anti-Cdc6 0.1ml

Anti-Visfatin-1/PBEF1(NT) hu、 mo、 rat、MK /FITC 熒光素標(biāo)記內(nèi)脂素/內(nèi)臟脂肪素(N端抗體)IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh phospho-GABBR1 (Ser923) 磷酸化gamma氨基B型受體1抗體 規(guī)格 0.1ml

CK18 peptide 細(xì)胞角蛋白18多肽抗原Multi-class antibodies規(guī)格： 0.5mg

MDK Protein Human 重組人 Midkine / MDK 蛋白

MDA-MB-435S 人導(dǎo)管癌細(xì)胞

HA Others Influenza B 乙型 (B/Florida/4/2006) 血凝素HA2 (Hemagglutinin) 人細(xì)胞裂解液 (陽性對照)

A549人非小細(xì)胞細(xì)胞 A549 cells in human non small cell lung cancer F-12K+10% FBS

人細(xì)胞;5637(HTB-9)

人胚胎心肌組織來源細(xì)胞;CCC-HEH-2 人小氣道上皮細(xì)胞完全培養(yǎng)基 100mL

CL-0282HO-8910PM(人高轉(zhuǎn)移細(xì)胞)5×106cells/瓶×2

TNFSF11 Others Mouse 小鼠 RANKL / OPGL / TNFSF11 / CD254 人細(xì)胞裂解液 (陽性對照)

小鼠頜下腺上皮細(xì)胞完全培養(yǎng)基 100mL

L W-3A小鼠皮下結(jié)締組織細(xì)胞 L W-3A mice subcutaneous connective tissue cells DMEM培養(yǎng)基+10%FBS

IL1A Protein Mouse 重組小鼠 IL-1 alpha / IL1A / IL1F1 蛋白

P3X63Ag8.653(小鼠細(xì)胞) 5×106cells/瓶×2 L6(大鼠成肌細(xì)胞)

磷酸化雷帕霉素靶蛋白復(fù)合體2抗體規(guī)格 MDK Protein Human 重組人 Midkine / MDK 蛋白

MDA-MB-435S 人導(dǎo)管癌細(xì)胞

HA Others Influenza B 乙型 (B/Florida/4/2006) 血凝素HA2 (Hemagglutinin) 人細(xì)胞裂解液 (陽性對照)

A549人非小細(xì)胞細(xì)胞 A549 cells in human non small cell lung cancer F-12K+10% FBS

人細(xì)胞;5637(HTB-9)

人胚胎心肌組織來源細(xì)胞;CCC-HEH-2 人小氣道上皮細(xì)胞完全培養(yǎng)基 100mL